Prednisone for MG Richard J. Barohn, MD Gary Gronseth, MD

Slides:



Advertisements
Similar presentations
Palumbo A et al. Proc ASH 2013;Abstract 536.
Advertisements

Heather D. Mannuel, MD, MBA March 12, 2008
FACULTY OF MEDICINE PHYSIOLOGY DEPARTMENT DR. NERMEN MADY DR. RAMEZ.
A patient with severe Crohn's disease, an ileal stricture and proximal dilation on CTE should have medical therapy first Uma Mahadevan MD Professor of.
Azathioprine for IBD : Better the devil you know Jeremy D. Sanderson.
June Disease / Deficiency. Bones are living organs Calcium is deposited and withdrawn from bones daily. Bones continue to deposit more bone than.
Therapeutic Plasma Exchange for Myasthenia Gravis Clifford Blieden, MD Houston Methodist Hospital Department of Pathology and Genomic Medicine, Division.
Dose-Toxicity Study of Oral Prednisone in Ocular Myasthenia Michael Benatar, Mike McDermott, Gil Wolfe and Don Sanders.
Review of the Paleo Diet: Advantages and Disadvantages By Michaela M. Phillips.
Annual General Practitioner Study Day 2012 Men’s Health Workshop Managing side effects of male cancer therapy Dr Conleth Murphy, Consultant Medical Oncologist.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 19 Adrenocorticosteroids.
ATLAS Clinical Trial Commentary Dr Eric Topol Chairman and Professor, Department of Cardiology Director of the Joseph J Jacobs Center for Thrombosis and.
Polymyalgia Rheumatica A micro-teach of BSR & BHPR guidelines
Peritoneal Dialysis End Stage Renal Disease Causes and Treatment Methods.
Sophia M. Chung, M.D. Depts of Ophthalmology &
Myasthenia Gravis Victor Politi,M.D.
Glucocorticoid-Induced Osteoporosis (GIO) Nguyen Thy Khue, MD, PhD Department of Endocrinology, HoChiMinh City University of Medicine and Pharmacy.
“Antibiotics and corticosteroids: Indications and approaches”
The Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Brief Protocol Training NIH-NINDS U01 NS NETT CCC U01 NS NETT SDMC U01 NS
Medical and Surgical Management of MG Brian A. Crum, MD Department of Neurology Mayo Clinic Rochester, MN MGFA National Meeting, St. Louis May, 2010.
Potatoes or Bacon: Which is better for weight loss? Laura Zakowski, MD.
Nutritional issues for children with asthma. High Incidence Rate Among: Males Low socioeconomic status African Americans Family history of asthma or allergies.
SPARCL Stroke Prevention by Aggressive Reduction in Cholesterol Levels trial.
Corticosteroids.
You Can Never Stop a Biologic
Neurology Chapter of IAP
Thrice-Weekly Glatiramer Acetate for Relapsing Forms of Multiple Sclerosis: Findings from the GALA Study Fred D. Lublin, MD Saunders Family Professor of.
The Century Health Trial A Comprehensive Integrated Strategy For Managing CAD K. Lance Gould, M.D. Martin Bucksbaum Distinguished University Chair, Professor.
Myasthenia gravis Treatment Recommendations Treatment Anticholinesterases Immunosuppressants Thymectomy Plasma exchange and IVIG.
brains&GAINS November 2, a.m. Center For Tomorrow
ALZHEIMER’S DISEASE DIAGNOSIS and TREATMENT J. Wesson Ashford, M.D., Ph.D. Stanford / VA Alzheimer’s Center VAMC, Palo Alto, California October, 2004 Slides.
Iron as a Treatment: Successes and Failures. What next? Christopher J Earley MB, BCh, PhD, FRCP(I) Professor Department of Neurology Johns Hopkins School.
Myasthenia Gravis.
Cost Versus Benefit of Plant Extracts (Pycnogenol ® ) in Diabetes Risk Reduction.
Prednisone 8 Month Old Cheap Prednisone Meds 477 prednisone dose for dogs with allergies prednisone treatment of cancer strep throat prednisone hydroxyzine.
Jennifer Vilarino Period: 5
Daclatasvir + Sofosbuvir +/- Ribavirin in Genotype 1-3 Trial
Randomized Controlled Trials of Methotrexate & Mycophenolate in MG
Rachel Kim, PharmD Candidate Cone Health Family Medicine
Plasmapheresis Treatment for Myasthenia Gravis
Lithium Practical Prescribing
Recurrent falls in an older woman with diabetes
Lupus Nephritis Treatment
Plasmapheresis or IVIG for GBS
HOPE: Heart Outcomes Prevention Evaluation study
Neal B, et al. Diabetes Care 2015;38:403–411
MSG Scientific Annual Meeting Sept 2016, Snowbird, UT Gil I. Wolfe, MD
Diabetic Lumbosacral Radiculoplexopathy DLSRP
Glucocorticoids in Nonendocrine Disorders
Pyridostigmine for MG Richard J. Barohn, MD
Kantarjian H et al. Cancer 2009;[Epub ahead of print].
R-CHOP Stem Cell Transplantation for Follicular Lymphoma
Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS I)
Essential Questions How may lifestyle or nutritional choices lead to a chronic disease?
DiRECT (Diabetes Remission Clinical Trial)
Ledipasvir-Sofosbuvir +/- Ribavirin for 8 or 12 weeks in HCV GT1 ION-3
Three Steps to Interpret Clinical Trials
Thymectomy for Myasthenia Gravis? YES!
Screening, Lipid Stabilization, and Placebo Run-in
Dr. PJ Devereaux on behalf of POISE Investigators
Figure 2 Clinical course and response to therapy in 6 Australian patients with HMGCR antibodies The clinical course, creatine kinase (CK) levels, Medical.
Reducing the Risk of Developing Diabetes
POPE-2 Trial design: Patients with moderate to large pericardial effusion after cardiac surgery were randomized to colchicine 2 mg loading dose, then 1.
Corticosteroids in the ICU
Major Hormone Secreting Glands of the Endocrine System
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
The efficacy and safety of omalizumab in pediatric allergic asthma
Cardiovascular System
Algorithm based on the 2015 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) recommendations for the management of polymyalgia.
Insulin Delivery Systems Atlanta Diabetes Associates
Presentation transcript:

Prednisone for MG Richard J. Barohn, MD Gary Gronseth, MD www.rrnmf.com Richard J. Barohn, MD Gary Gronseth, MD Chair, Department of Neurology Vice Chair, Department of Neurology Gertrude and Dewey Ziegler Professor of Neurology University Distinguished Professor Vice Chancellor for Research University of Kansas Medical Center Kansas City, KS

Treatment of MG Cholinesterase Inhibitors Pyridostigmine (Mestinon) Prostigmine (Neostigmine) Immunosuppressive Drug Therapies Plasmapheresis Surgery Thymectomy

Benefit from Alternate-Day Prednisone in Myasthenia Gravis 5 MG Pts Prednisone 100mg every other day Single AM dose With daily K⁺, antacids, low Na/ carb diet All improved in 24-72 hrs 1 CR JR Warmolts, WK Engel. N Engl J Med 1972; 286:17-20

Treatment of Myasthenia Gravis with Prednisone Jenkins RB. Lancet 8 MG pts Rx with prednisone for between 6 and 25 months Alternate day trials 7/8 improved

ALERNATE-DAY PREDNISONE: PRELIMINARY REPORT OF A DOUBLE-BLIND CONTROLLED STUDY Howard et al, Ann NYAS 1976 13 Pts: 6 Pred / 7 Plac 100 mg qod x 6 mo vs. plac All on Anticholinesterase Imp No Imp Rem Pred 3 3 0 Plac 3 4 0 Rep Stim - No Diff Conc: No stats 2° small #s Not all Pred pts imp Some Plac pts imp

Prednisone Rx For MG U. Virginia Experience: Pascuzzi & Johns 116 Pts – Anals Neurol 1984;15:291 Dose – Initiation 60-80 mg/day Maintenance alternate day Early exacerbation 48% 9% required intubation 28% asymptomatic – pharmacologic remission 52% marked improvement 15% moderate improvement 5% no improvement Mean Time t o Max Benefit – 5.5 Months Range 2 weeks to 6 years Only 14% of Responders were able to D/C Prednisone Thymectomy did not improve likelihood of D/C steroids: 8/51 vs. 5/42 Sghirlanzoni et al, Neurol 1984;34:170 60 pts; Imp 72% Evoli et al, Eur Neurol 1992;32:31 104 pts; Imp 81.7%

Treatment of myasthenia gravis with a methylprednisolone pulse: a double blind study Lindberg, Andersen, Lefvert. Acta Neurol Scand 1998;97:370-373 20 pts 10 IVMP / 10 PLAC 2 grams IVMP x 2 days At 2 weeks: IVMP imp muscle fatigue by 27 points PLAC unchanged; P = 0.0006 8/10 responded in IVMP group & 1/9 in PLAC Duration of imp – 4, 6, 6, 8, 10, 14 weeks 1 pt in IVMP reported initial worsening No other AE’s

Prednisone Rx for MG High Dose 100 mg/day x 2 weeks Then 100 mg qod until much better Then taper 5 mg q 2 wks Requires initial inpatient admission Low / Slow Approach Seybold & Drachman 1974 Gradual inc to avoid initial worsening 10 mg/day; inc by 10 mg q 5-7 days Then switch to qod In-between Approach Mycophenolate trial protocol - Pred 20 mg/day No randomized trial of prednisone in MG, but it works! Probably most effective drug for MG Even given potential side effects

MG Treatment Side effects of prednisone Type 2 muscle fiber atrophy But true steroid myopathy rare Hypertension Glucose intolerance (diabetes) Low potassium Fluid retention and weight gain Cataracts Risk of infection Osteoporosis, aseptic femoral necrosis

MG Treatment Concurrent Management Chest X-ray and PPD or new Quantiferon TB blood test prior to treatment Vitamin D and calcium supplementation for prophylaxis against osteoporosis Baseline bone density DEXA scan and then annual Alendronate (Fosamax) as needed Dietary consult to instruct on low carbohydrate, low sodium diet Check potassium, glucose, blood pressure, eyes on follow-up

Corticosteroid Treatment for MG Rx for MG since 1970 Pred can decrease AChR-Ab level (Tindall, 1980) Improvement begins to occur in 2-4 weeks Maximum benefit in 6 months Transient worsening occurs in 50% of patients during first week “Remission” is often steroid dependent Still most effective therapy for MG